BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18772140)

  • 1. TRAF6 specifically contributes to FcepsilonRI-mediated cytokine production but not mast cell degranulation.
    Yang YJ; Chen W; Carrigan SO; Chen WM; Roth K; Akiyama T; Inoue J; Marshall JS; Berman JN; Lin TJ
    J Biol Chem; 2008 Nov; 283(46):32110-8. PubMed ID: 18772140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
    Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
    Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The limited contribution of Fyn and Gab2 to the high affinity IgE receptor signaling in mast cells.
    Barbu EA; Zhang J; Siraganian RP
    J Biol Chem; 2010 May; 285(21):15761-8. PubMed ID: 20335178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells.
    Gomez G; Gonzalez-Espinosa C; Odom S; Baez G; Cid ME; Ryan JJ; Rivera J
    J Immunol; 2005 Dec; 175(11):7602-10. PubMed ID: 16301670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
    Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
    J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
    Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
    Front Immunol; 2018; 9():1771. PubMed ID: 30116247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells.
    MacNeil AJ; Yang YJ; Lin TJ
    J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin.
    Ishizuka T; Oshiba A; Sakata N; Terada N; Johnson GL; Gelfand EW
    J Biol Chem; 1996 May; 271(22):12762-6. PubMed ID: 8662803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
    Loniewski KJ; Patial S; Parameswaran N
    Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
    Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
    Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of calcium ionophore A23187-induced activation of IkappaB kinase 2 in mast cells.
    Hosokawa J; Suzuki K; Nakagomi D; Tamachi T; Takatori H; Suto A; Nakajima H
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():37-43. PubMed ID: 23711852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeletal Protein 4.1R Is a Positive Regulator of the FcεRI Signaling and Chemotaxis in Mast Cells.
    Draberova L; Draberova H; Potuckova L; Halova I; Bambouskova M; Mohandas N; Draber P
    Front Immunol; 2019; 10():3068. PubMed ID: 31993060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired signaling via the high-affinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells.
    Pivniouk VI; Snapper SB; Kettner A; Alenius H; Laouini D; Falet H; Hartwig J; Alt FW; Geha RS
    Int Immunol; 2003 Dec; 15(12):1431-40. PubMed ID: 14645152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells.
    Péterfy H; Tóth G; Pecht I; Erdei A
    Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells.
    Gonzalez-Espinosa C; Odom S; Olivera A; Hobson JP; Martinez ME; Oliveira-Dos-Santos A; Barra L; Spiegel S; Penninger JM; Rivera J
    J Exp Med; 2003 Jun; 197(11):1453-65. PubMed ID: 12782712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWAP-70 regulates mast cell FcepsilonRI-mediated signaling and anaphylaxis.
    Sivalenka RR; Sinha M; Jessberger R
    Eur J Immunol; 2008 Mar; 38(3):841-54. PubMed ID: 18236401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol Suppresses Cytokine Production Linked to FcεRI-MAPK Activation in IgE-Antigen Complex-Exposed Basophilic Mast Cells and Mice.
    Han SY; Choi YJ; Kang MK; Park JH; Kang YH
    Am J Chin Med; 2015; 43(8):1605-23. PubMed ID: 26621445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation.
    Klemm S; Gutermuth J; Hültner L; Sparwasser T; Behrendt H; Peschel C; Mak TW; Jakob T; Ruland J
    J Exp Med; 2006 Feb; 203(2):337-47. PubMed ID: 16432253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.